Nabel EG, Braunwald E (2012) A tale of coronary artery disease and myocardial infarction. N Engl J Med. 366:54–63. https://doi.org/10.1056/NEJMra1112570
Article
CAS
PubMed
Google Scholar
Shabana N, Ashiq S, Ijaz A, Khalid F, Ul Saadat I, Khan K, et al. Genetic risk score (GRS) constructed from polymorphisms in the PON1, IL-6, ITGB3, and ALDH2 genes is associated with the risk of coronary artery disease in Pakistani subjects. Lipids Health Dis. 2018;17:224. https://doi.org/10.1186/s12944-018-0874-6
Ashiq S, Ashiq K, Shabana S, Shahid SU, Qayyum M, Sadia H (2020) Prevalence and role of different risk factors with emphasis on genetics in development of pathophysiology of coronary artery disease (CAD). Pak Heart J. 52:279–287
Google Scholar
Ozaki K, Tanaka T. Molecular genetics of coronary artery disease. J Hum Genet. 2016; 61(1):71-77. https://doi.org/10.1038/jhg.2015.70
Liu Z, Pericak-Vance MA, Goldschmidt-Clermont P, Seo D, Wang L, Rundek T, et al. Coronary collateralization shows sex and racial-ethnic differences in obstructive artery disease patients. PLoS One. 2017;12:e0183836. https://doi.org/10.1371/journal.pone.0183836
Abbasi SH, Sundin Ö, Jalali A, Soares J, Macassa G. Ethnic differences in the risk factors and severity of coronary artery disease: a patient-based study in Iran. J Racial Ethn Health Disparities. 2018;5:623-631. https://doi.org/10.1007/s40615-017-0408-3
Khera AV, Kathiresan S. Genetics of coronary artery disease: discovery, biology and clinical translation. Nat Rev Genet. 2017;18:331-344. https://doi.org/10.1038/nrg.2016.160
Field PA, Vasan RS. LDL-cholesterol is not the only clinically relevant biomarker for coronary artery disease or acute coronary syndrome. Clin Pharmacol Ther. 2018;104:232-234. https://doi.org/10.1002/cpt.1126
Shahid SU, Cooper JA, Beaney KE, Li K, Rehman A, Humphries SE. Effect of SORT1, APOB and APOE polymorphisms on LDL-C and coronary heart disease in Pakistani subjects and their comparison with Northwick Park Heart Study II. Lipids Health Dis. 2016;15:83. https://doi.org/10.1186/s12944-016-0253-0
Pleva L, Kusnierova P, Plevova P, Hilscherova S, Karpisek M, Zapletalova J, et al. The APOE ɛ2 allele is associated with increased plasma apolipoprotein E levels in patients with coronary artery disease. Cor et Vasa. 2017;59:e235-e2e9. https://doi.org/10.1016/j.crvasa.2016.11.011
Burman D, Mente A, Hegele RA, Islam S, Yusuf S, Anand SS. Relationship of the ApoE polymorphism to plasma lipid traits among South Asians, Chinese, and Europeans living in Canada. Atherosclerosis. 2009;203:192-200. https://doi.org/10.1016/j.atherosclerosis.2008.06.007
Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am Journal Epidemiol. 2002;155:487-495. https://doi.org/10.1093/aje/155.6.487
Larifla L, Armand C, Bangou J, Blanchet-Deverly A, Numeric P, Fonteau C, et al. Association of APOE gene polymorphism with lipid profile and coronary artery disease in Afro-Caribbeans. PLoS One. 2017;12:e0181620. https://doi.org/10.1371/journal.pone.0181620
Abd El-Aziz TA, Mohamed RH. LDLR, ApoB and ApoE genes polymorphisms and classical risk factors in premature coronary artery disease. Gene. 2016;590:263-269. https://doi.org/10.1016/j.gene.2016.05.032
Afroze D, Yousuf A, Tramboo NA, Shah ZA, Ahmad A. ApoE gene polymorphism and its relationship with coronary artery disease in ethnic Kashmiri population. Clin Exp Med. 2016; 551-556. https://doi.org/10.1007/s10238-015-0389-7
Atis O, Sahin S, Ceyhan K, Ozyurt H, Akbas A, Benli I (2016) The distribution of apolipoprotein E gene polymorphism and apolipoprotein E levels among coronary artery patients compared to controls. Eurasian J Med. 48(2):90–94. https://doi.org/10.5152/eurasianjmed.2015.25
Article
CAS
PubMed
PubMed Central
Google Scholar
Cheema AN, Bhatti A, Wang X, Ali J, Bamne MN, Demirci FY, et al. APOE gene polymorphism and risk of coronary stenosis in Pakistani population. Biomed Res Int. 2015. https://doi.org/10.1155/2015/587465
Long Y, Zhao XT, Liu C, Sun YY, Ma YT, Liu XY, et al. A Case-Control Study of the Association of the Polymorphisms of MTHFR and APOE with Risk Factors and the Severity of Coronary Artery Disease. Cardiology. 2019;142:149-157. https://doi.org/10.1159/000499866
Ghaznavi H, Kiani AA, Soltanpour MS. Association study between DNA methylation and genetic variation of APOE gene with the risk of coronary artery disease. Mol Biol Res Commun. 2018;7:173-179. doi: https://doi.org/10.22099/mbrc.2018.30955.1352
Arafa S, Abdelsalam S, El-Gilany AH, Mosaad YM, Abdel-Ghaffar A. Endothelial nitric oxide synthase Glu 298 Asp (G894T) and Apolipoprotein E gene polymorphism as possible risk factors for coronary heart disease among Egyptians. Egypt Heart J. 2018;70:393-401. https://doi.org/10.1016/j.ehj.2018.08.001
Heidari MM, Foruzannia SK, Khatami M, Hadadzadeh M, Meybodi ME (2013) Apolipoprotein E gene polymorphism in Iranian coronary atherosclerosis patients candidate for coronary artery bypass graft. Iran J Basic Med Sci. 16:841–844
PubMed
PubMed Central
Google Scholar
Hou J, Deng Q, Guo X, Deng X, Zhong W, Zhong Z. Association between apolipoprotein E gene polymorphism and the risk of coronary artery disease in Hakka postmenopausal women in southern China. Lipids Health Dis. 2020;19:1-7. https://doi.org/10.1186/s12944-020-01323-6
Souza DR, Nakachima L, Biagioni RB, Nakazone MA, Pinhel MA, Trindade DM, et al. Relevance of apolipoprotein E4 for the lipid profile of Brazilian patients with coronary artery disease. Braz J Med Biol Res. 2007;40:189-197. https://doi.org/10.1590/S0100-879X2006005000065
Đjan I, Stokić E, Sakač D, Đan M, Obreht D, Erak M, et al. Case-control study of apoE gene polymorphism in young CHD patients and controls in the Serbian population. Arch Biol Sci. 2011;63:89-98. https://doi.org/10.2298/ABS1101089D
Anoop S, Misra A, Meena K, Luthra K (2010) Apolipoprotein E polymorphism in cerebrovascular & coronary heart diseases. Indian J Med Res. 132:363–378
CAS
PubMed
Google Scholar
Chaudhary R, Likidlilid A, Peerapatdit T, Tresukosol D, Srisuma S, Ratanamaneechat S, et al. Apolipoprotein E gene polymorphism: effects on plasma lipids and risk of type 2 diabetes and coronary artery disease. Cardiovasc Diabetol. 2012;11:36. https://doi.org/10.1186/1475-2840-11-36
Utermann G, Hees M, Steinmetz A. Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man. Nature. 1977;269:604-607. https://doi.org/10.1038/269604a0
Mahley RW, Rall Jr SC. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genom Hum G. 2000;1:507-537. https://doi.org/10.1146/annurev..genom.1.1.
Wang YL, Sun LM, Zhang L, Xu HT, Dong Z, Wang LQ, et al. Association between Apolipoprotein E polymorphism and myocardial infarction risk: A systematic review and meta-analysis. FEBS Open Bio. 2015;5:852-858. https://doi.org/10.1016/j.fob.2015.10.006
Song Y, Stampfer MJ, Liu S. Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med. 2004;141:137-147. https://doi.org/10.7326/0003-4819-141-2-200407200-00013
Zhang MD, Gu W, Qiao SB, Zhu EJ, Zhao QM, Lv SZ. Apolipoprotein E gene polymorphism and risk for coronary heart disease in the Chinese population: a meta-analysis of 61 studies including 6634 cases and 6393 controls. PloS one. 2014;9:e95463. https://doi.org/10.1371/journal.pone.0095463
Wilson PW, Schaefer EJ, Larson MG, Ordovas JM. Apolipoprotein E alleles and risk of coronary disease: a meta-analysis. Arterioscler Thromb Vasc Biol. 1996;16:1250-1255. https://doi.org/10.1161/01.ATV.16.10.1250
Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-34. doi: https://doi.org/10.1136/bmj.315.7109.629